Argonaute proteins are essential components of microRNA (miRNA)-and small interfering (siRNA)-mediated post-transcriptional gene-silencing pathways. In mammals, Argonaute2 (Ago2) is the catalytic center of the RNA-induced silencing complex (RISC) that recognizes and endonucleolytically cleaves messenger RNAs of complementary sequence. Although Ago2 is essential for RISC activity, the mechanisms regulating Argonaute protein expression are largely unknown. Here we report that Ago2 expression is dependent on miRNA abundance and that unloaded Ago2 protein is unstable. We observed a low level of Ago2 protein in Dicer-or DGCR8-deficent mouse embryonic stem cells (ESCs) that could be rescued by reintroduction of the respective cDNAs or by transfection of miRNAs or siRNAs. We found expression of Ago2 protein from a transgene to be similarly regulated, further supporting a post-transcriptional control mechanism. Inhibition of Hsc70/Hsp90 led to decreased Ago2 expression consistent with the reported role of this chaperone complex in RISC assembly. We furthermore found that the degradation of Ago2 was specifically blocked by inhibition of the lysosome, but not the proteasome. Our results illuminate a novel feedback mechanism that post-transcriptionally couples Ago2 protein levels with small RNA abundance with implications for RNA-interference (RNAi) and miRNA function.
INTRODUCTION
Gene silencing pathways triggered by small interfering RNAs (siRNAs) and microRNAs (miRNAs) function in a sequence-specific manner to regulate mRNA stability and protein translation, and in some cases, heterochromatin formation in diverse organisms (Ketting 2011) . To do so, these regulatory RNAs associate with Argonaute (Ago) proteins as a part of a RNA-induced silencing complex (RISC). Ago proteins bind short duplex RNAs of ∼22 bp and subsequently one strand (guide strand) is stably incorporated while the other strand (passenger strand) gets degraded (Kawamata and Tomari 2010) . Loaded Ago serves then as a guide to specifically recognize target mRNAs to inhibit their translation and/or induce their cleavage. Of the four Ago proteins (Ago1-4), Ago2 is the only mammalian Ago protein with intrinsic endonuclease activity, encoded by its PIWI domain (Hammond et al. 2001; Liu et al. 2004; Rivas et al. 2005) . Moreover, the endonucleolytic activity of Ago2 has also been implicated in miRNA biogenesis (Diederichs and Haber 2007; O'Carroll et al. 2007; Cheloufi et al. 2010 ).
Numerous reports have identified Hsp90 (as well as other heat shock proteins) as an Ago-interacting protein (Tahbaz et al. 2001; Maniataki and Mourelatos 2005; Hock et al. 2007; Landthaler et al. 2008) . Hsp90 is part of a multiprotein chaperone complex that functions to regulate the folding, turnover, or activity of a small set of "client" proteins (Pratt et al. 2008) . Illustrative of this function is the example of steroid receptors (Pratt and Toft 2003) . The Hsp90 chaperone complex regulates steroid signaling by opening the ligandbinding clefts of steroid receptors to allow the access of the steroid ligand (Pratt et al. 2008 ). Hsp90 action requires ATP hydrolysis, and in the presence of specific inhibitors that mimic ATP-binding such as geldanamycin or its analog 17-AAG, client proteins become unstable and are quickly degraded (Pratt et al. 2008) . Indeed, Hsp90 inhibitors were shown to significantly reduce the levels of human Ago proteins as well as their recruitment to Processing bodies (P-bodies), discrete cytoplasmic speckles involved in miRNA-mediated repression (Pare et al. 2009; Johnston et al. 2010 ). In the report by Johnston et al. (2010) , the action of Hsp90 inhibitors on Ago2 levels was found to be counteracted by the proteasome inhibitor MG132, and it was concluded that Hsp90 functions to protect unloaded Ago proteins from proteasomal degradation. Two recent in vitro studies indicate that Hsp90 is specifically required for loading small RNA duplexes into fly-Ago1, fly-Ago2, and hAgo2, but not for subsequent duplex 1 unwinding or target cleavage (Iwasaki et al. 2010; Miyoshi et al. 2010) . Altogether, these reports propose that Hsp90 functions to change the conformation of Ago proteins, likely by hydrolyzing ATP, enabling it to accommodate the small RNA "ligands" (Iwasaki et al. 2010; Johnston et al. 2010; Miyoshi et al. 2010 ).
Here we report that miRNA ligands post-transcriptionally regulate the levels of Ago2 and that unloaded Ago2 protein is unstable. Specifically, we show that Dicer and DGCR8-deficient mouse embryonic stem cells (ESCs) display reduced Ago2 protein, but not mRNA levels, compared with their wild-type counterparts. This effect could be rescued by restoring miRNA levels, either by expressing their respective cDNAs or by transfection of small RNAs. We found that expression of Ago2 protein from a transgene was similarly regulated, supporting a post-transcriptional mechanism. We found that inhibition of the Hsc70/Hsp90 chaperone machinery led to decreased Ago2 levels, consistent with the reported role of the chaperones in the loading of Ago2. Furthermore, we found that the degradation of Ago2 was specifically blocked by inhibition of autophagy, but not the proteasome. Given that levels of Ago proteins within the cell reportedly influence global miRNA levels, our results illuminate a novel feedback mechanism that post-transcriptionally couples Ago2 protein levels with miRNA/siRNA abundance to form stoichiometric and functional RISCs.
RESULTS AND DISCUSSION
To investigate the role of miRNA ligands in Ago2 protein stability, we assessed Ago2 protein levels in mouse embryonic stem cells (ESCs) that lack DGCR8, a key component of the Microprocessor required for canonical miRNA biogenesis (Gregory et al. 2004; Wang et al. 2007 ). DGCR8 KO ESCs, hence, lack mature canonical miRNAs (Fig. 1A) . DGCR8 KO ESCs displayed dramatically reduced Ago2 protein levels compared with their wild-type counterpart (V6.5) (Fig. 1A) . Importantly, Ago2 protein levels were increased in DGCR8 KO cells rescued with a pFlag-DGCR8 expressing construct, but not a characterized DGCR8 mutant construct impaired for RNA binding (pFlag-DGCR8-DSRB) ( Fig. 1B,C ; Yeom et al. 2006) . To rule out the possibility that the DGCR8 protein is itself required to maintain high Ago2 protein levels (e.g., via protein-protein interactions or other unknown mechanisms) and to explore whether particular miRNAs are required for Ago2 stability, we transfected DGCR8 KO ESCs with premiRNAs or with small (∼22 nt) RNAs which are either direct or downstream products of Microprocessor activity, respectively. Introduction of pre-miR-302, a miRNA normally expressed in ESCs, resulted in increased Ago2 protein levels (Fig. 1D ). This increase was not specific to pre-miR-302, since other miRNA precursors were also able to up-regulate Ago2 (Fig. 1E) . Notably, transfection of a control pre-miRNA, whose sequence is not encoded in the genome, also increases the Ago2 protein levels of DGCR8 KO cells. Ago2 also increased upon transfection of small RNA duplexes, but to a lesser extent by the transfection of single-stranded small RNAs (Fig. 1F) . These results indicate that small RNA ligands are required to maintain high Ago2 protein levels. Mouse Dicer KO ESCs also lack mature miRNAs as well as other types of small endogenous RNAs (Babiarz et al. 2008) . In agreement with our previous findings, the levels of Ago2 protein were reduced in Dicer KO compared with heterozygous Dicer +/− ESCs (Fig.  1G ). Ago2 protein levels were increased in Dicer KO ESCs rescued with a pFlag-Dicer expressing construct (Fig. 1H) . Furthermore, we investigated Ago2 protein levels following a global shutdown of miRNA processing. Specifically, we utilized tamoxifen inducible Dicer-null mouse embryonic fibroblasts (MEFs) derived from mouse embryos that are either heterozygous (Dicer +/− ) or homozygous (Dicer KO) for a targeted allele of Dicer (Tan et al. 2009; Gantier et al. 2011) . Treatment with 4-hydroxytamoxifen (4-OHT) induced deletion of Dicer and a concomitant reduction in miRNA levels (Fig. 1I ). Supporting our previous findings, cells treated with 4-OHT also displayed reduced Ago2 protein levels, indicating that the observed effects are not ESC specific and are also seen in differentiated cells (Fig. 1I) .
To determine whether the observed decrease in Ago2 levels in cells with no miRNAs (or reduced levels of miRNAs) is a post-transcriptional event, we measured Ago2 transcript levels by quantitative Real-Time PCR (qRT-PCR). We found no significant change in Ago2 mRNA levels between miRNAdeficient cells and their wild-type counterpart, indicating that miRNAs are able to stabilize Ago2 expression post-transcriptionally ( Fig. 2A) . To confirm the observed post-transcriptional regulation, we reasoned that transfection of a construct expressing the Ago2 cDNA under the control of an exogenous promoter would be expressed at lower levels in miRNA-deficient than in wild-type ESCs. To test this, we transfected a plasmid expressing pFlag-Ago2 or control pFlag-Hsp90 under the CMV promoter into V6.5 and DGCR8 KO cells. Indeed, we detected Flag-Ago2 protein at higher levels in wild-type than in DGCR8 KO cells (Fig. 2B ). In contrast, control Flag-Hsp90 was detected at comparable levels in both cell types. Upon cotransfection of a pFlag-DGCR8 expressing construct into DGCR8 KO cells, we were able to detect Flag-Ago2 at comparable levels to wild-type cells (Fig. 2C ). These findings strongly indicate that Ago2 is post-transcriptionally regulated by miRNAs, and in the absence of miRNAs Ago2 protein is unstable and degraded. We hypothesized that Ago2 that is impaired in small RNA binding would be expressed at lower levels than wild-type Ago2. Mutations in the PAZ domain of Ago2 were shown to decrease small RNA-binding activity . Consistent with our model, when transfected into mouse ESCs, two characterized Ago2 mutants containing nine or 10 mutations in the PAZ domain are expressed at lower levels than wild-type Ago2 (Fig. 2D) . Finally, in support of our model, we found that increasing miRNA levels in wild-type ESCs by overexpressing of pFlag-DGCR8 or pre-miR-302 results in a twofold increase in Ago2 protein levels (Fig. 2E) .
Cross-regulation between components of the small RNA biogenesis machinery has been widely observed. For instance, the main components of the Microprocessor responsible for processing primary miRNA transcripts into miRNA precursors (pre-miRNAs), Drosha and DGCR8, have been shown to post-transcriptionally regulate each other. The Drosha-DGCR8 complex cleaves the hairpins embedded in the 5 ′ end of the DGCR8 mRNA, thereby destabilizing the mRNA and DGCR8 and, in turn, stabilizes the Drosha protein via protein-protein interactions (Han et al. 2009; Triboulet et al. 2009 ). Nuclear pre-miRNAs are recognized by exportin5 (Xpo5) and transported to the cytoplasm, where the RNase III Dicer in collaboration with the RNA-binding proteins Trbp and Pact generates the short RNA duplexes of ∼22 bp.
Xpo5 was shown to post-transcriptionally regulate Dicer expression by exporting the Dicer mRNA out of the nucleus (Bennasser et al. 2011) . The protein-protein association of Pact and Trbp with Dicer reportedly enhances Dicer stability and processing activity (Chendrimada et al. 2005; Haase et al. 2005) . Finally, levels of Ago proteins within the cell have been shown to influence global miRNA levels. While ectopic expression of Ago proteins increases mature miRNAs, MEFs and hematopoietic cells lacking the Ago2 gene exhibit reduced levels of mature miRNAs (Diederichs and Haber 2007; O'Carroll et al. 2007 ). These changes in mature miRNA levels mediated by increased Ago expression suggest that Ago proteins assist to stabilize miRNAs likely by protecting bound miRNAs from the action of exoribonucleases (Winter and Diederichs 2011) . Our findings indicate that miRNAs, in turn, serve to stabilize Ago2 protein levels and microRNAs stabilize Ago2 expression www.rnajournal.org 607 uncover a novel feedback mechanism to titrate the levels of Ago2 protein with the availability of mature miRNAs to form stoichiometric and functional RISCs.
It has been proposed that Hsp90 functions to change the conformation of Ago proteins, likely by hydrolyzing ATP, enabling it to accommodate the small RNA ligands (Iwasaki et al. 2010; Johnston et al. 2010; Miyoshi et al. 2010) . Mammalian cells treated with geldanamycin (or its analog 17-AAG) to specifically inhibit the function of Hsp90, exhibit reduced levels of Ago proteins (Johnston et al. 2010) . However, in Drosophila cell extracts the stability of Ago proteins does not change upon inhibition of the Hsp90/Hsc70 chaperone complexes (Iwasaki et al. 2010; Miyoshi et al. 2010) . Therefore, to test whether the heat-shock chaperones play a role in Ago2 stability in mouse ESCs, we treated cells with 17-AAG and PES (2-phenylethynesulfonamide) to specifically inhibit Hsp90 and Hsc70, respectively. Both inhibitors significantly reduced Ago2 levels in wild-type (V6.5) as well as miRNA-deficient ESCs previously transfected with pre-miR-302 (Fig. 3A,  B) . In addition, we performed gain-of-function experiments by overexpressing Hsp90 in DGCR8 KO ESCs. While transfection of a pFlag-Hsp90-expressing construct failed to increase Ago2 protein levels in the absence of miRNAs, Hsp90 overexpression was able to increase Ago2 levels of DGCR8 KO ESCs previously transfected with a miRNA precursor (Fig. 3C) . Altogether, these results indicate that Hsp90 plays a role in stabilizing loaded Ago2 and highlights the importance of miRNA ligands in Ago2 protein levels. The report by Johnston et al. (2010) indicates that the effect of geldanamycin treatment could be abrogated by addition of the proteasome inhibitor MG132, suggesting that unloaded Ago2 is degraded via the proteasome. We reasoned that in miRNA-deficient cells, where Ago2 is unloaded, inhibition of the proteasome would increase Ago2 protein levels. However, MG132 treatment failed to up-regulate Ago2 levels in DGCR8 KO ESCs (Fig.  4A) . Importantly, we detected increased p53 levels, indicating .5 and DGCR8 KO ESCs were transfected with either empty vector (pFlag-CMV2), control pFlag-Hsp90, or increasing amounts of pFlag-Ago2 as indicated. Total cell extracts were collected after 48 h p-t and equal amounts of extracts were subjected to Flag IP and Western blot with a-Flag antibody. (C) V6.5 and DGCR8 KO ESCs were cotransfected with pFlag-Ago2, pFlag-Hsp90, or pFlag-CMV2, and either pFlag-DGCR8 or empty vector as indicated. Total cell extracts were collected after 48 h p-t and equal amounts of extracts were subjected to Flag IP and Western blot with a-Flag antibody. (D) V6.5 cells were transfected with empty vector, control pFlag-Hsp90, wild-type, or PAZ mutant Flag-Ago2 constructs. Total cell extracts were collected after 48 h p-t and equal amounts of extracts were subjected to Flag IP and Western blot with a-Flag antibody. Asterisk indicates a the presence of a contaminating band that serves as a loading control for the IPs (E, left) V6.5 cells were transfected with empty vector or pFlag-DGCR8, and Ago2 levels in total cell extracts were analyzed 48 h p-t by Western blot. (Right) V6.5 cells were either mock transfected or transfected with (20 nM final) pre-miR-302. Ago2 levels in total cell extracts were analyzed 48 h p-t by Western blot. Tubulin or Actin serves as loading control. The numbers on the bottom of Western blots indicate the relative Ago2 abundance (normalized to loading control). a successful inhibition of the proteasome. Moreover, we did not detect any increase in levels of Ago2 protein even in wild-type ESCs treated with MG132, where the stem-cell factor Trim71 has been reported to function as an E3 Ubiquitin ligase targeting Ago2 for proteasomal degradation (Rybak et al. 2009 ). However, other recent studies found Ago2 protein levels to be unchanged in Trim71-depleted ESCs and neural progenitors, raising doubts about the relevance of Trim71-mediated control of Ago2 ubiquitination and stability (Chang et al. 2012; Chen et al. 2012) . Ago2 was initially identified as a membrane-bound protein and later showed to associate with multivesicular bodies for secretion and/or lysosomal degradation (Cikaluk et al. 1999; Tahbaz et al. 2001; Gibbings et al. 2009; Lee et al. 2009 ). We hypothesized that inhibition of autophagy may increase unloaded Ago2 levels. To test this idea, we treated DGCR8 KO ESCs with Bafilomycin A1, which has been shown to inhibit acidification and protein degradation in the lysosome (Yoshimori et al. 1991) . Indeed, we found that Bafilomycin A1 treatment increased Ago2 protein levels in miRNA-deficient as well as wild-type ESCs (Fig. 4B) . Treatment with a different autophagy inhibitor, 3-Methyladenine (3-MA), which has been shown to inhibit autophagosome formation by inhibiting type III phosphatidylinositol 3-kinases (PI-3K) (Blommaart et al. 1997) , also increased Ago2 protein levels (Fig. 4C) .
These results indicate that the lysosome likely plays a role in the degradation of unloaded and perhaps also loaded Ago2. While this work was under review, Gibbings et al. (2012) also reported the involvement of selective autophagy in the degradation of unloaded Ago2 in HeLa cells, which is in accordance with our findings in mouse ESCs.
In vitro studies indicate that the Hsp90 (and Hsc70) chaperone machinery is required for loading of small RNA duplexes into Ago proteins, but not for subsequent strand separation or target cleavage (Iwasaki et al. 2010; Miyoshi et al. 2010 ). These studies propose that the chaperone machinery utilizes ATP to mediate a conformational opening of Ago proteins so that they can receive bulky small RNA duplexes. Interestingly, a recent report showed that purified recombinant Ago2 that was not loaded with a small RNA is more susceptible to digestion by thermolysin than loaded Ago2, suggesting that, at least in vitro, small RNA loading confers a conformational change that protects Ago2 from degradation by proteases (Elkayam et al. 2012) . Our study demonstrates that Ago2 levels are tightly coupled to miRNA levels in vivo (Fig. 4D ). This novel feedback mechanism therefore ensures stoichiometric RISC assembly and could potentially prevent the accumulation of unloaded Ago2 protein or Ago2 loaded with "nonspecific ligands," which might otherwise have deleterious consequences to the cell transcriptome.
Our findings also support a role for the Hsc70/Hsp90 chaperone machinery in the stabilization of loaded Ago2 and implicate the autophagy pathway in the destabilization of unloaded Ago2 (Fig. 4D) . Given the physical association of Ago2 with Hsc70, one possibility is that unloaded Ago2 is subject to a specialized form of autophagy called chaperone-mediated autophagy (CMA) (Kaushik and Cuervo 2012) . In this model the Hsc70/Hsp90 complex would play a dual role in both RISC assembly and in cases where miRNA levels are limiting, and may also be responsible for initiating degradation of unloaded Ago2. However, the autophagy inhibitor 3-MA has been shown to selectively inhibit autophagy but not CMA, since CMA does not require formation of autophagosomes (Finn et al. 2005) . We find that 3-MA is indeed a potent up-regulator of Ago2 levels, indicating that CMA does not likely play a role in Ago2 stability. In support of this idea, Gibbings et al. (2012) recently reported that the autophagy receptor NDP52 is responsible to target unloaded Ago2 for degradation. However, it remains possible that CMA may also contribute to the regulation of Ago2. Another aspect of Ago2 regulation that still remains unclear is what factors/processes are required for the turnover of loaded Ago2 and whether autophagy may also be involved.
MATERIALS AND METHODS
Cell culture, cell lines, and inhibitors (Gantier et al. 2011; Tan et al. 2009 ). MG132 (Z-Leu-Leu-Leu-al; Sigma, C2211) and Bafilomycin A1 (Sigma, B1793) were dissolved in DMSO and added to cells for 5 h to a final concentration of 20 μM and 0.1 μM, respectively. 3-MA (3-Methyladenine; Sigma, M9281) was dissolved in water and added to cells at a final concentration of 5 mM for 24 h. PES (2-Phenylethynesulfonamide; Sigma, P0122) and 17-AAG (17-demethoxy-17-allylaminogeldanamycin; LC LABS, A-6880) were dissolved in DMSO and added to cells to a final concentration of 20 µM for 18 and 24 h, respectively.
DNA constructs and RNA
The cDNA of human Hsp90AA1 was cloned into the XbaI and SmaI sites of pFlag-CMV2 using the primers Fw: 5 ′ -AAAAATCT AGAATGCCTGAGGAAACCCAGAC-3 ′ and Rv: 5 ′ -AAAACCCGGGTTAGTCTACTTCTT CCATGCGTGATGTGTCG-3 ′ . Human Flag-DGCR8 wt and DSRB mutant were previously described and were generated by site-directed mutagenesis (Yeom et al. 2006) . Human Ago2 (pIRESneo-Flag/HA-Ago2) and human Dicer (pFRT/TO/Flag/HA-DEST-Dicer) expressing constructs were obtained from Addgene (plasmids 10822 and 19881, respectively) . For Figure 2D , the cDNA of human wt, PAZ9, and PAZ10 Ago2 mutants were PCR amplified from the Myc-Ago2, PAZ9, and PAZ10 constructs ) and subcloned into the EcoRI/XbaI sites of pFlag-CMV2. Precursor mi-RNAs for negative control (pre-control, AM17110) and mmu-miR302a were purchased from Ambion. Premmu-let-7a1, pre-mmu-miR-21, and premmu-miR-138 were purchased from Dharmacon. The sequence for hsa-let-7 guide and passenger strands are as follows: guide 5 ′ -UG AGGUAGUAGUUUGUAC-3 ′ ; passenger: 5 ′ -CUGUACAGGCCACUGCCU-3
′ . GL2 and GL3 sense sequences have been previously described (Elbashir et al. 2001) .
Cell transfections
For transfection of DNA and RNA, Lipofectamine 2000 (Invitrogen, 11668-019) was used according to the manufacturer's instructions. Otherwise noted, cells were collected 48 h after transfection.
Cell extracts, Flag IP, and Western blotting
Cells were harvested in lysis buffer (20 mM Tris-HCl at pH 8.0, 137 mM NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, 10% [v/v] Glycerol, 1.5 mM MgCl2, 1 mM DTT, 0.2 mM PMSF). For Flag-IP, Flag-tagged proteins were affinity-purified using α-Flag M2 agarose beads (Sigma) and washed 6× with BC-100 buffer (20 mM Tris at pH 7.6, 100 mM KCl, 10 mM β-Mercaptoethanol, 10% [v/v] Glycerol, 0.2% [v/v] Nonidet P-40, 0.2 mM PMSF) before elution with 0.5 mg/mL Flag peptide. Cell extracts and affinity eluates were analyzed by SDS-PAGE and Western blotting. Antibodies used in this study are listed as follows: α-Tubulin, (Abcam, ab6046), α-Ago2 (Cell Signaling, C34C6), α-Flag (Sigma, A8592), α-p53 (Leica Microsystems, NCL-p53-CM5p), and α-Actin (Sigma, A2066). All Western blots were quantified using the ImageJ software from the National Institutes of Health (Bethesda, MD).
qRT-PCR and miRNA quantification
Total RNA samples were isolated using TRIzol reagent (Invitrogen, 15596-018). For mRNA measurement, 100 ng-1 μg of total RNA was reverse transcribed using random hexamers and SuperScript III reverse transcriptase (Invitrogen, 18080) . Quantitative PCR was performed using iQ SYBR Green Supermix (Gantier et al. 2011) . For miRNA quantification, 5 ng of total RNA was reverse transcribed using gene-specific stemloop RT primers and Multiscribe reverse transcriptase (Applied Biosystems, Part #4311235). The resulting cDNAs were mixed with TaqMan Universal PCR Master Mix, No AmpErase UNG (Applied Biosystems, Part #4324018). Mouse snoRNA-142 was used as normalization control. Quantitative PCR was then performed using iCycler iQ Multicolor Real-Time PCR Detection System (Bio-Rad).
